Alcohol-related hepatitis admissions increased 50% in the first months of the COVID-19 pandemic in the USA - PubMed (original) (raw)
. 2022 Apr;42(4):762-764.
doi: 10.1111/liv.15172. Epub 2022 Feb 24.
Affiliations
- PMID: 35094494
- DOI: 10.1111/liv.15172
Alcohol-related hepatitis admissions increased 50% in the first months of the COVID-19 pandemic in the USA
Humberto C Gonzalez et al. Liver Int. 2022 Apr.
Abstract
Early reports suggest that alcohol misuse increased in 2020 as a result of the COVID-19 pandemic. Using retrospective data from Henry Ford Health System in Detroit MI-an area that experienced an early and severe COVID-19 outbreak-we investigated the impact of the pandemic on alcohol-related liver disease (ARLD) in the summer of 2020 compared with the same period in 2016-2019. Both the number of ARLD admissions and the proportion of total admissions represented by ARLD patients increased significantly in 2020 compared with previous years. The number of ARLD admissions as a proportion of all hospitalizations was 50% higher in 2020 than in 2016-2019 (0.31% vs 0.21%; P = .0013); by September 2020, the number of admissions was 66% higher than previous years. Despite racial and geographical disparities in direct and indirect COVID-related stressors across the Detroit metropolitan area, the demographic profile of ARLD patients did not change compared with previous years.
Keywords: SARS-CoV-2; alcohol-related liver disease; alcoholic hepatitis; cirrhosis; hospitalization.
© 2022 John Wiley & Sons A/S . Published by John Wiley & Sons Ltd.
Comment in
- No impact of COVID-19 epidemic on decompensation of alcoholic liver disease: Results from a single centre in Milan.
Masetti C, Colapietro F, Voza A, Aghemo A. Masetti C, et al. Liver Int. 2022 Dec;42(12):2921-2922. doi: 10.1111/liv.15407. Epub 2022 Sep 14. Liver Int. 2022. PMID: 36004560 No abstract available. - No impact of COVID-19 epidemic on decompensation of alcoholic liver disease: Results from a single-centre in Milan.
Masetti C, Colapietro F, Voza A, Aghemo A. Masetti C, et al. Liver Int. 2022 Nov;42(11):2581-2582. doi: 10.1111/liv.15400. Epub 2022 Sep 6. Liver Int. 2022. PMID: 36066183 Free PMC article. No abstract available.
Similar articles
- Alcohol-related hepatitis admissions decline in 2021 after a 2020 surge attributed to the COVID-19 pandemic.
Gonzalez HC, Nimri FM, Lu M, Zhou Y, Rupp LB, Trudeau S, Gordon SC. Gonzalez HC, et al. Hepatol Int. 2023 Dec;17(6):1637-1644. doi: 10.1007/s12072-023-10569-y. Epub 2023 Jul 28. Hepatol Int. 2023. PMID: 37505324 - The Liverpool alcohol-related liver disease algorithm identifies twice as many emergency admissions compared to standard methods when applied to Hospital Episode Statistics for England.
Dhanda A, Bodger K, Hood S, Henn C, Allison M, Amasiatu C, Burton R, Cramp M, Forrest E, Khetani M, MacGilchrist A, Masson S, Parker R, Sheron N, Simpson K, Vergis N, White M; BASL ARLD SIG National Service Evaluation Group. Dhanda A, et al. Aliment Pharmacol Ther. 2023 Feb;57(4):368-377. doi: 10.1111/apt.17307. Epub 2022 Nov 17. Aliment Pharmacol Ther. 2023. PMID: 36397658 Free PMC article. - Impact of the COVID-19 Pandemic on Hospitalizations for Alcoholic Hepatitis or Cirrhosis in Alberta, Canada.
Shaheen AA, Kong K, Ma C, Doktorchik C, Coffin CS, Swain MG, Burak KW, Congly SE, Lee SS, Sadler M, Borman M, Abraldes JG. Shaheen AA, et al. Clin Gastroenterol Hepatol. 2022 May;20(5):e1170-e1179. doi: 10.1016/j.cgh.2021.10.030. Epub 2021 Oct 26. Clin Gastroenterol Hepatol. 2022. PMID: 34715379 Free PMC article. - Current treatment options for alcohol-related liver disease.
Hazeldine S, Sheron N. Hazeldine S, et al. Curr Opin Gastroenterol. 2014 May;30(3):238-44. doi: 10.1097/MOG.0000000000000065. Curr Opin Gastroenterol. 2014. PMID: 24662843 Review. - Substance use during the COVID-19 pandemic: What is really happening?
Mellos E, Paparrigopoulos T. Mellos E, et al. Psychiatriki. 2022 Mar 28;33(1):17-20. doi: 10.22365/jpsych.2022.072. Epub 2022 Feb 21. Psychiatriki. 2022. PMID: 35255473 Review. English, Greek, Modern.
Cited by
- Incidence, characteristics, and risk factors of new liver disorders 3.5 years post COVID-19 pandemic in the Montefiore Health System in Bronx.
Peng T, Duong KS, Lu JY, Chacko KR, Henry S, Hou W, Fiori KP, Wang SH, Duong TQ. Peng T, et al. PLoS One. 2024 Jun 13;19(6):e0303151. doi: 10.1371/journal.pone.0303151. eCollection 2024. PLoS One. 2024. PMID: 38870207 Free PMC article. - Racial and ethnic disparities in alcohol-associated liver disease in the United States: A systematic review and meta-analysis.
Anouti A, Seif El Dahan K, Rich NE, Louissaint J, Lee WM, Lieber SR, Arab JP, Zhang BY, Patel MJ, Thimphittaya C, Díaz LA, Gregory DL, Kozlitina J, VanWagner LB, King AC, Mitchell MC, Singal AG, Cotter TG. Anouti A, et al. Hepatol Commun. 2024 Mar 18;8(4):e0409. doi: 10.1097/HC9.0000000000000409. eCollection 2024 Apr 1. Hepatol Commun. 2024. PMID: 38497931 Free PMC article. - Impact of the COVID-19 pandemic on the incidence and type of infections in hospitalized patients with cirrhosis: a retrospective study.
Cuyàs B, Huerta A, Poca M, Alvarado-Tapias E, Brujats A, Román E, Guarner C, Escorsell À, Soriano G. Cuyàs B, et al. Sci Rep. 2024 Feb 1;14(1):2718. doi: 10.1038/s41598-024-52452-2. Sci Rep. 2024. PMID: 38302563 Free PMC article. - Fuel to the fire: The impact of COVID-19 on alcohol-associated hepatitis.
Sengupta S, Dasarathy S. Sengupta S, et al. Alcohol Clin Exp Res (Hoboken). 2023 Dec;47(12):2223-2226. doi: 10.1111/acer.15204. Epub 2023 Oct 9. Alcohol Clin Exp Res (Hoboken). 2023. PMID: 38151782 No abstract available. - COVID-19 + Cirrhosis = Excess Hospital Confinement, Excess Casualties.
Gonzalez HC, Trudeau S. Gonzalez HC, et al. Dig Dis Sci. 2023 Dec;68(12):4290-4291. doi: 10.1007/s10620-023-08106-w. Epub 2023 Oct 21. Dig Dis Sci. 2023. PMID: 37864740 No abstract available.
References
REFERENCES
- Weerakoon SM, Jetelina KK, Knell G. Longer time spent at home during COVID-19 pandemic is associated with binge drinking among US adults. Am J Drug Alcohol Abuse. 2021;47:98-106.
- The Nielsen Company. Rebalancing the ‘COVID-19 Effect’ on alcohol sales. Volume 2021, 2020.
- Pollard MS, Tucker JS, Green HD Jr. Changes in adult alcohol use and consequences during the COVID-19 pandemic in the US. JAMA Netw Open. 2020;3:e2022942.
- Chen PH, Ting PS, Almazan E, Chander G, Cameron AM, Gurakar A. Inter-hospital escalation-of-care referrals for severe alcohol-related liver disease with recent drinking during the COVID-19 pandemic. Alcohol Alcohol. 2021. Online ahead of print.
- Chung W, Min M, Kothadia S, et al. Increased burden of alcohol-related gastrointestinal and liver diseases during the CoViD-19 pandemic: a hospital system-wide audit. Gastroenterology. 2021;160:S-778.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous